Cellular fate of a modular DNA delivery system mediated by silica nanoparticles.
about
Nanotechnology, nanotoxicology, and neuroscienceAmorphous Silica Particles Relevant in Food Industry Influence Cellular Growth and Associated Signaling Pathways in Human Gastric Carcinoma CellsUptake and intracellular localization of submicron and nano-sized SiO₂ particles in HeLa cells.New method to prepare very stable and biocompatible fluorescent silica nanoparticlesSilica nanoparticles as a delivery system for nucleic acid-based reagents.Probing the in vitro mechanism of action of cationic lipid/DNA lipoplexes at a nanometric scaleSiO(2) Nanoparticles Induced Cytotoxicity by Oxidative Stress in Human Bronchial Epithelial Cell, Beas-2B.Cellular uptake of magnetic nanoparticle is mediated through energy-dependent endocytosis in A549 cellsGold nanoparticles administration induces disarray of heart muscle, hemorrhagic, chronic inflammatory cells infiltrated by small lymphocytes, cytoplasmic vacuolization and congested and dilated blood vessels.Exposure to gold nanoparticles produces cardiac tissue damage that depends on the size and duration of exposureCalcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a reviewThe toxicity outcome of silica nanoparticles (Ludox®) is influenced by testing techniques and treatment modalitiesDelivery of the autofluorescent protein R-phycoerythrin by calcium phosphate nanoparticles into four different eukaryotic cell lines (HeLa, HEK293T, MG-63, MC3T3): Highly efficient, but leading to endolysosomal proteolysis in HeLa and MC3T3 cells.Polymeric core-shell nanoparticles for therapeutics.Template synthesized nanotubes for biomedical delivery applications.Immunostimulatory effects of silica nanoparticles in human monocytes.Nanovehicular intracellular delivery systems.Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives.Nonporous Silica Nanoparticles for Nanomedicine Application.Biopharmaceutics and therapeutic potential of engineered nanomaterials.Preparation and characterization of novel chitosan-protamine nanoparticles for nucleus-targeted anticancer drug delivery.Non-invasive administration of biodegradable nano-carrier vaccines.Mesoporous silica nanoparticles for intracellular controlled drug delivery.Drug delivery from structured porous inorganic materials.Activation of stress-related signalling pathway in human cells upon SiO2 nanoparticles exposure as an early indicator of cytotoxicity.Time and space resolved uptake study of silica nanoparticles by human cells.Recent applications of the combination of mesoporous silica nanoparticles with nucleic acids: development of bioresponsive devices, carriers and sensors.Genotoxicity of amorphous silica particles with different structure and dimension in human and murine cell lines.An overview on the role of silica-based materials in vaccine development.Antibody-functionalized nano test tubes target breast cancer cells.Enhanced transfection of tumor cells in vivo using "Smart" pH-sensitive TAT-modified pegylated liposomes.Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system.Mesoporous Silica Nanoparticles for Cancer Therapy: Energy-Dependent Cellular Uptake and Delivery of Paclitaxel to Cancer CellsGenotoxicity evaluation of amorphous silica nanoparticles of different sizes using the micronucleus and the plasmid lacZ gene mutation assay.Nonviral gene delivery: thinking of silica.Fluorescent dye-doped silica nanoparticles: new tools for bioapplications.
P2860
Q24650444-AE75718E-15D2-4E4B-99FF-EC61AD072BA6Q29249068-55E46C4F-2C4D-4D22-A25B-54FCDC77DC7EQ33794952-04CBF30B-4545-43A4-BB35-E6CF02378320Q33887120-F831CE80-7AF6-4998-A4C2-462AC9408872Q34080775-22EB4E0A-AFF3-4B52-A987-F3A7D0886161Q34609262-522E8A31-EB71-4F36-BCF1-E951EDF72C65Q35546582-234E3F8D-A782-4A2E-9318-568A54231B46Q35622436-87396EE1-B5A9-4E0F-BAAD-995DF35D907CQ35753646-C8E3B63D-B3C8-4C77-A836-32AD4EFA2672Q35753841-DD6CBD42-EFDB-4480-A940-AEEFEF3DE974Q36160994-0353DC14-C8B2-49AC-999F-06B0B7B34902Q36291515-84B45CF3-5E40-49E0-9488-4A8CDED30C7CQ36393940-10D797B7-3797-4BAD-A567-16AEEA0BB972Q36478861-177E7C22-73FC-47DD-ACFE-69FDF2D0131EQ36918079-278C1661-D1D6-4BC5-AD3A-3C5AFCF504CBQ37034106-6D2ED61E-BBBE-4E89-A6BF-E70CC60B4FC7Q37058812-E94B572E-BD77-4DA1-9678-C8F0AE57A873Q37130501-63ED38B2-EFA5-483D-9029-F09C71A0C1B5Q37131939-F9473BC8-DF42-4C17-9612-D0A1A6D01349Q37273411-ABD88F5F-AE80-4B85-8225-054CEACD65C6Q37423279-049A1661-3D72-4A08-B7FC-9F1681D2CC87Q37596856-E74DE396-2608-4A1B-BEB4-14496AFAA039Q37778327-C9F1FD6B-9EAD-4B3A-AC6C-8183807D4629Q37849730-97C79627-035E-412C-9AA7-2199CACC5474Q38275446-8B252EA3-88F5-40B2-824C-C15B5D5D2755Q38569728-78E6640E-72B5-4C70-B804-B8F268A9EBBDQ39096024-3127A0C3-62F4-45CC-AE7E-7F4815EA3840Q39209346-F80A2B59-A773-47A0-8C6C-4EED095736C2Q39781727-2FC48663-2DC8-4AFC-A607-FB9259C31184Q39977399-E67BD84E-3F6D-4672-BCF0-9E6A0D0D4921Q40098786-01D20032-1A81-4D61-939F-D6EB54179864Q41830969-3B30EABD-9F27-43C5-AD5F-F24DDFCA77DBQ42646371-C6460876-3058-455C-ADB7-84CF3EBCA60EQ42823196-520C20B1-EF2B-4B5F-ABB6-7E45F281DBB7Q45868441-A471856F-3FAE-479E-AB26-C7F6AC99D69BQ48704117-AAFD1EEF-804C-4EED-AAF8-E8A2700DD589
P2860
Cellular fate of a modular DNA delivery system mediated by silica nanoparticles.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Cellular fate of a modular DNA delivery system mediated by silica nanoparticles.
@en
Cellular fate of a modular DNA delivery system mediated by silica nanoparticles.
@nl
type
label
Cellular fate of a modular DNA delivery system mediated by silica nanoparticles.
@en
Cellular fate of a modular DNA delivery system mediated by silica nanoparticles.
@nl
prefLabel
Cellular fate of a modular DNA delivery system mediated by silica nanoparticles.
@en
Cellular fate of a modular DNA delivery system mediated by silica nanoparticles.
@nl
P356
P1476
Cellular fate of a modular DNA delivery system mediated by silica nanoparticles.
@en
P2093
W Mark Saltzman
P304
P356
10.1021/BP049648W
P577
2005-03-01T00:00:00Z